Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

ClinicalTrials.gov ID: NCT02141074

Public ClinicalTrials.gov record NCT02141074. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Single-arm Multicentre Non-controlled Phase 3 a Trial Investigating Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Prophylaxis and Treatment of Bleeding Episodes in Previously Untreated Patients With Haemophilia B (FIX Activity Below or Equal to 2 Percent)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted globally. The aim of the trial is to investigate the safety and efficacy of nonacog beta pegol (N9-GP) in previously untreated patients with Haemophilia B.

Study identification

NCT ID
NCT02141074
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
54 participants

Conditions and interventions

Eligibility (public fields only)

Age range
0 Years to 6 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2, 2014 (Actual)
Primary completion
Oct 27, 2022 (Actual)
Completion
Oct 27, 2022 (Actual)
Last update posted
Dec 23, 2025

2014 – 2022

United States locations

U.S. sites
23
U.S. states
16
U.S. cities
23
Facility City State ZIP Site status
Miller Children's Hospital Long Beach Long Beach California 90806 —
Children's Hospital Los Angeles - Endocrinology Los Angeles California 90027 —
Shands Hospital at the University of Florida Gainesville Florida 32610 —
Nemours Chld Clnc Jacksonville Jacksonville Florida 32207 —
Augusta University Augusta Georgia 30912 —
Hope for Kids Macon Georgia 31201 —
St. Luke's Mountain States Tumor Institute Boise Idaho 83712 —
University Of Iowa Iowa City Iowa 52242 —
Children's Hosp-New Orleans New Orleans Louisiana 70118-5720 —
Johns Hopkins University_Baltimore_3 Baltimore Maryland 21205 —
Univ of NE Med Center_Omaha Omaha Nebraska 68198-6828 —
North Shore Long Island Jewish Medical Center New Hyde Park New York 11040 —
University of North Carlolina-Chapel Hill Chapel Hill North Carolina 27514 —
Novant Hlth Vasc Ins Charlotte Charlotte North Carolina 28204 —
Univ Hosp Cleveland Med Ctr Cleveland Ohio 44106 —
Dayton Children Hemostati Ctr Dayton Ohio 45404 —
Penn State MS Hershey Med Ctr Hershey Pennsylvania 17033 —
St Christopher Hosp for Child Philadelphia Pennsylvania 19134 —
Medical University Of SC Charleston South Carolina 29425 —
Vanderbilt Hemostasis Thrombosis Clinic Nashville Tennessee 37232 —
Univ of Utah Primary Children's Hospital Salt Lake City Utah 84113 —
University of Virginia Children's Hospital Charlottesville Virginia 22903 —
Children's Hsptl Of The Kings Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02141074, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 23, 2025 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02141074 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →